These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinical value of the detection of hepatitis C virus core antigen].
    Author: Lu YC, Jiang ZY, Kuang YL, Chen WS, Tan YZ, Li DR.
    Journal: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587.
    Abstract:
    AIM: To explore the value of detecting hepatitis C virus core antigen in HCV infected diseases. METHODS: The HCV-RNA was tested by fluorescent quantitative polymerase chain reaction (FQ-PCR). The core antigens of HCV and anti-HCV were tested by enzyme-linked immunosorbent assay (ELISA). RESULTS: The positive rate of HCV-RNA in 191 patients was 71.2%, about 136 in 191. The positive rate of anti-HCV was 97.4%, about 186 in 191. The positive rate of HCV core antigen was 33.0%, about 63 in 191. After antiviral therapy for 2 patients,their HCV-RNA and anti-HCV were detected negative but their HCV core antigen was detected positive. In another patient, his anti-HCV was negative but his HCV core antigen was positive. CONCLUSION: As a supplemental test for anti-HCV examination the detection of HCV core antigen is of important clinical value in HCV infection diagnosis.
    [Abstract] [Full Text] [Related] [New Search]